Literature DB >> 17319158

Structural and functional analysis of dengue virus RNA.

Diego E Alvarez1, Maria F Lodeiro, Claudia V Filomatori, Silvana Fucito, Juan A Mondotte, Andrea V Gamarnik.   

Abstract

Sequences and structures present at the 5' and 3' UTRs of RNA viruses play crucial roles in the initiation and regulation of translation, RNA synthesis and viral assembly. In dengue virus, as well as in other mosquito-borne flaviviruses, the presence of complementary sequences at the ends of the genome mediate long-range RNA-RNA interactions. Dengue virus RNA displays two pairs of complementary sequences (CS and UAR) required for genome circularization and viral viability. In order to study the molecular mechanism by which these RNA-RNA interactions participate in the viral life cycle, we developed a dengue virus replicon system. RNA transfection of the replicon in mosquito and mammalian cells allows discrimination between RNA elements involved in translation and RNA synthesis. We found that mutations within CS or UAR at the 5' or 3' ends of the RNA that interfere with base pairing did not significantly affect translation of the input RNA but seriously compromised or abolished RNA synthesis. Furthermore, a systematic mutational analysis of UAR sequences indicated that, beside the role in RNA cyclization, specific nucleotides within UAR are also important for efficient RNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17319158

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  14 in total

1.  Composition of the sequence downstream of the dengue virus 5' cyclization sequence (dCS) affects viral RNA replication.

Authors:  Peter Friebe; José Peña; Marie O F Pohl; Eva Harris
Journal:  Virology       Date:  2011-12-01       Impact factor: 3.616

2.  The 5' and 3' downstream AUG region elements are required for mosquito-borne flavivirus RNA replication.

Authors:  Peter Friebe; Pei-Yong Shi; Eva Harris
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

3.  Helices alpha2 and alpha3 of West Nile virus capsid protein are dispensable for assembly of infectious virions.

Authors:  Petra Schlick; Christian Taucher; Beate Schittl; Janina L Tran; Regina M Kofler; Wolfgang Schueler; Alexander von Gabain; Andreas Meinke; Christian W Mandl
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

4.  Interplay of RNA elements in the dengue virus 5' and 3' ends required for viral RNA replication.

Authors:  Peter Friebe; Eva Harris
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

Review 5.  Functional interplay among the flavivirus NS3 protease, helicase, and cofactors.

Authors:  Kuohan Li; Wint Wint Phoo; Dahai Luo
Journal:  Virol Sin       Date:  2014-03-26       Impact factor: 4.327

Review 6.  A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies.

Authors:  Muhammad Faheem; Ummar Raheel; Muhammad Nasir Riaz; Naghmana Kanwal; Farakh Javed; Najam us Sahar Sadaf Zaidi; Ishtiaq Qadri
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

7.  Characterization of recombinant dengue-2 virus derived from a single nucleotide substitution in the 5' noncoding region.

Authors:  Vijittra Leardkamolkarn; Wipawan Sirigulpanit; Richard M Kinney
Journal:  J Biomed Biotechnol       Date:  2010-03-22

8.  Identification of RNA helicase A as a new host factor in the replication cycle of foot-and-mouth disease virus.

Authors:  Paul Lawrence; Elizabeth Rieder
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

Review 9.  Genome cyclization as strategy for flavivirus RNA replication.

Authors:  Sergio M Villordo; Andrea V Gamarnik
Journal:  Virus Res       Date:  2008-09-09       Impact factor: 3.303

10.  Insights into the molecular evolution of Dengue virus type 4 in Puerto Rico over two decades of emergence.

Authors:  Estelle Martin; Maritza Chirivella; Juliene K G Co; Gilberto A Santiago; Duane J Gubler; Jorge L Muñoz-Jordán; Shannon N Bennett
Journal:  Virus Res       Date:  2015-11-10       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.